Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in gene therapy, biochemistry, glycobiology, stem cell biology or a related topic. Candidates with experience in gene therapy or glycobiology are encouraged to apply.
This project has a Band 3 fee. Details of our different fee bands can be found on our website (View Website). For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website (View Website).
Informal enquiries may be made directly to the primary supervisor.
Bigger 2014 Discovery medicine 17 (94) 207-215 Novel Approaches and Mechanisms in
Hematopoietic Stem Cell Gene Therapy –review.
Wilkinson 2012 PlosOne 7 (4) e35787 Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
Sergijenko 2013 Molecular Therapy 21 (10) 1938-49 Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease.